Roberta L. Beauchamp

2.4k total citations
41 papers, 1.8k citations indexed

About

Roberta L. Beauchamp is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Roberta L. Beauchamp has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Neurology and 13 papers in Physiology. Recurrent topics in Roberta L. Beauchamp's work include Neurofibromatosis and Schwannoma Cases (14 papers), Tuberous Sclerosis Complex Research (13 papers) and Meningioma and schwannoma management (8 papers). Roberta L. Beauchamp is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (14 papers), Tuberous Sclerosis Complex Research (13 papers) and Meningioma and schwannoma management (8 papers). Roberta L. Beauchamp collaborates with scholars based in United States, Canada and Malaysia. Roberta L. Beauchamp's co-authors include Vijaya Ramesh, James F. Gusella, David W. Yandell, Denise Pinney, Ann D. Thor, Jolanta Kupryjańczyk, Anat Stemmer‐Rachamimov, Douglas A. Bell, S M Edgerton and Charo Gonzalez-Agosti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Roberta L. Beauchamp

38 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberta L. Beauchamp United States	24	657	575	465	308	282	41	1.8k
Arend Koch Germany	34	1.4k 2.1×	415 0.7×	333 0.7×	260 0.8×	299 1.1×	85	2.6k
Cinzia Lavarino Spain	24	986 1.5×	713 1.2×	499 1.1×	336 1.1×	66 0.2×	73	2.0k
Gayatry Mohapatra United States	24	1.2k 1.8×	410 0.7×	286 0.6×	187 0.6×	142 0.5×	34	2.0k
Laura Papi Italy	25	1.2k 1.8×	766 1.3×	859 1.8×	292 0.9×	892 3.2×	68	3.2k
Catherine Miquel France	22	755 1.1×	654 1.1×	442 1.0×	271 0.9×	329 1.2×	57	2.2k
Griffith Harsh United States	18	742 1.1×	273 0.5×	159 0.3×	190 0.6×	245 0.9×	36	1.8k
Kerry Mullaney United States	13	463 0.7×	501 0.9×	112 0.2×	670 2.2×	118 0.4×	24	1.5k
Hilde Brems Belgium	28	1.3k 2.0×	325 0.6×	1.9k 4.1×	806 2.6×	456 1.6×	74	3.4k
M.H. Breuning Netherlands	29	1.1k 1.7×	314 0.5×	229 0.5×	171 0.6×	85 0.3×	60	2.6k
John B. McIntyre Canada	19	538 0.8×	208 0.4×	71 0.2×	278 0.9×	196 0.7×	37	1.4k

Countries citing papers authored by Roberta L. Beauchamp

Since Specialization

Citations

This map shows the geographic impact of Roberta L. Beauchamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta L. Beauchamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta L. Beauchamp more than expected).

Fields of papers citing papers by Roberta L. Beauchamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta L. Beauchamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta L. Beauchamp. The network helps show where Roberta L. Beauchamp may publish in the future.

Co-authorship network of co-authors of Roberta L. Beauchamp

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta L. Beauchamp. A scholar is included among the top collaborators of Roberta L. Beauchamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta L. Beauchamp. Roberta L. Beauchamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Szkop, Krzysztof J., Françis Robert, Roberta L. Beauchamp, et al.. (2025). TSC2 loss in neural progenitor cells suppresses mRNA translation of neurodevelopmental genes. Brain. 148(8). 2935–2950.

Oblinger, Janet L., Roberta L. Beauchamp, Françis Robert, et al.. (2024). Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in NF2-deficient models. Neuro-Oncology Advances. 6(1). vdae024–vdae024.

Jordan, Justin T., Roberta L. Beauchamp, Alona Muzikansky, et al.. (2023). Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2. Neuro-Oncology Advances. 5(1). vdad041–vdad041. 10 indexed citations

Robert, Françis, Krzysztof J. Szkop, Jennifer Wang, et al.. (2023). Translatome analysis of tuberous sclerosis complex 1 patient-derived neural progenitor cells reveals rapamycin-dependent and independent alterations. Molecular Autism. 14(1). 39–39. 4 indexed citations

Beauchamp, Roberta L., Serkan Erdin, Justin T. Jordan, et al.. (2020). mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. Journal of Biological Chemistry. 296. 100157–100157. 7 indexed citations

Beauchamp, Roberta L., Yanling Zhang, Saša Vasilijić, et al.. (2020). Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma. Scientific Reports. 10(1). 4211–4211. 22 indexed citations

Li, Lin, Ryan Walsh, Vilas Wagh, et al.. (2015). Mediator Subunit Med28 Is Essential for Mouse Peri-Implantation Development and Pluripotency. PLoS ONE. 10(10). e0140192–e0140192. 13 indexed citations

James, Marianne F., Roberta L. Beauchamp, Sangyeul Han, et al.. (2012). Regulation of mTOR Complex 2 Signaling in Neurofibromatosis 2–Deficient Target Cell Types. Molecular Cancer Research. 10(5). 649–659. 81 indexed citations

Beyer, Kim S., et al.. (2007). Mediator Subunit MED28 (Magicin) Is a Repressor of Smooth Muscle Cell Differentiation. Journal of Biological Chemistry. 282(44). 32152–32157. 23 indexed citations

10.

Lee, Ming‐Fen, Roberta L. Beauchamp, Kim S. Beyer, James F. Gusella, & Vijaya Ramesh. (2006). Magicin associates with the Src-family kinases and is phosphorylated upon CD3 stimulation. Biochemical and Biophysical Research Communications. 348(3). 826–831. 13 indexed citations

11.

Han, Sangyeul, Mark Bowser, Roberta L. Beauchamp, et al.. (2005). Alternative splicing in protein associated with Myc (Pam) influences its binding to c‐Myc. Journal of Neuroscience Research. 83(2). 222–232. 11 indexed citations

12.

Hewett, Jeffrey, Christoph Kamm, Heather Boston, et al.. (2004). TorsinB – perinuclear location and association with torsinA. Journal of Neurochemistry. 89(5). 1186–1194. 30 indexed citations

13.

Murthy, Vanishree, Sangyeul Han, Roberta L. Beauchamp, et al.. (2004). Pam and Its Ortholog Highwire Interact with and May Negatively Regulate the TSC1·TSC2 Complex. Journal of Biological Chemistry. 279(2). 1351–1358. 66 indexed citations

14.

James, Marianne F., et al.. (2004). A NHERF binding site links the βPDGFR to the cytoskeleton and regulates cell spreading and migration. Journal of Cell Science. 117(14). 2951–2961. 58 indexed citations

15.

Murthy, Vanishree, Anat Stemmer‐Rachamimov, Luciana Amaral Haddad, et al.. (2001). Developmental expression of the tuberous sclerosis proteins tuberin and hamartin. Acta Neuropathologica. 101(3). 202–210. 25 indexed citations

16.

Beauchamp, Roberta L., Patrick McNamara, Hope Northrup, et al.. (1998). Exon scanning of the entireTSC2 gene for germline mutations in 40 unrelated patients with tuberous sclerosis. Human Mutation. 12(6). 408–416. 46 indexed citations

17.

Stemmer‐Rachamimov, Anat, Lin Xu, Charo Gonzalez-Agosti, et al.. (1997). Universal absence of merlin, but not other ERM family members, in schwannomas.. PubMed. 151(6). 1649–54. 93 indexed citations

18.

Gonzalez-Agosti, Charo, Lin Xu, Denise Pinney, et al.. (1996). The merlin tumor suppressor localizes preferentially in membrane ruffles.. PubMed. 13(6). 1239–47. 95 indexed citations

19.

Ikeda, Hidetoshi, Roberta L. Beauchamp, Takashi Yoshimoto, & David W. Yandell. (1995). Detection of heterozygous mutation in the retinoblastoma gene in a human pituitary adenoma using PCR-SSCP analysis and direct sequencing. Endocrine Pathology. 6(3). 189–196. 8 indexed citations

20.

Rustgi, Anil K., Lin Xu, Denise Pinney, et al.. (1995). Neurofibromatosis 2 gene in human colorectal cancer. Cancer Genetics and Cytogenetics. 84(1). 24–26. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact